|Project Title||Enhancing TreeScan for Long-Term Follow-up (TreeScan Censoring)|
Thursday, June 15, 2017
A workgroup will be convened to modify the TreeExtraction code and TreeScan software to allow for differential follow-up time and making the searching risk window parameters more flexible. The HPV4 vaccine will serve as the test case for the new capability, and will be run on internal test data for two follow-up periods: 6 months and 12 months.
Judith C. Maro PhD, MS; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
Steven A. Anderson PhD, MPP; Rositsa Dimova PhD, MS; Adamma Mba-Jonas MD, MPH; Azadeh Shoaibi PhD, MHS, MS; Jawahar Tiwari PhD; Center for Biologics Evaluation and Research, FDA, Silver Spring, MD
David Cole BM; Meighan Rogers Driscoll MPH; Austin Cosgrove BS; Inna Dashevsky MS; Megan Reidy MPH; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
Martin Kulldorff PhD; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA